Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia (AML)

Explore clinical trials studying Acute Myeloid Leukemia (AML). Study availability and eligibility vary by location and protocol.

146 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia (AML) trial results

Completed

Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies

NCT00710528

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Cardiovascular Diseases, +29 more
Locations
  • Stanford Cancer Center Palo Alto, California, United States
  • The Sidney Kimmel Comprehensive Cancer Center at John Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia

NCT00401739

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Westmead Hospital Westmead, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia
  • Princess Alexandra Hospital Woolloongabba, Queensland, Australia
  • Institute of Medical & Veterinary Science Adelaide, South Australia, Australia
View Trial Details
Active, Not Recruiting

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

NCT04603001

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +17 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • University of California, Davis - Health Systems Sacramento, California, United States
  • H Lee Moffitt Cancer Center Tampa, Florida, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy

NCT02993523

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • City of Hope /ID# 154105 Duarte, California, United States
  • University of California, Los Angeles /ID# 154107 Los Angeles, California, United States
  • University of California, Davis Comprehensive Cancer Center /ID# 162725 Sacramento, California, United States
  • Emory Midtown Infectious Disease Clinic /ID# 162534 Atlanta, Georgia, United States
View all 172 locations
View Trial Details

Related conditions